CLSL — Crop Life Science Income Statement
0.000.00%
- IN₹522.00m
- IN₹791.95m
- IN₹1.31bn
- 22
- 79
- 36
- 40
Annual income statement for Crop Life Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 1,351 | 1,189 | 1,020 | 1,312 |
Cost of Revenue | ||||
Gross Profit | 445 | 514 | 426 | 390 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 1,286 | 1,127 | 966 | 1,232 |
Operating Profit | 65.2 | 62.2 | 54.6 | 80.7 |
Total Net Non Operating Interest Income / Expense | ||||
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 45.9 | 49.3 | 37.7 | 56 |
Provision for Income Taxes | ||||
Net Income After Taxes | 32.3 | 37 | 28.1 | 40.7 |
Net Income Before Extraordinary Items | ||||
Net Income | 32.3 | 37 | 28.1 | 40.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 32.3 | 37 | 28.1 | 40.7 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 1.88 | 2.14 | 1.62 | 3.39 |